JP2023550122A5 - - Google Patents
Info
- Publication number
- JP2023550122A5 JP2023550122A5 JP2023530634A JP2023530634A JP2023550122A5 JP 2023550122 A5 JP2023550122 A5 JP 2023550122A5 JP 2023530634 A JP2023530634 A JP 2023530634A JP 2023530634 A JP2023530634 A JP 2023530634A JP 2023550122 A5 JP2023550122 A5 JP 2023550122A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen
- alkyl
- compound according
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2018412.3 | 2020-11-23 | ||
| GBGB2018412.3A GB202018412D0 (en) | 2020-11-23 | 2020-11-23 | Malt-1 modulators ii |
| PCT/GB2021/053031 WO2022106857A1 (en) | 2020-11-23 | 2021-11-23 | Malt-1 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550122A JP2023550122A (ja) | 2023-11-30 |
| JP2023550122A5 true JP2023550122A5 (https=) | 2024-12-02 |
Family
ID=74046962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530634A Pending JP2023550122A (ja) | 2020-11-23 | 2021-11-23 | Ｍａｌｔ－１モジュレーター |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250051327A1 (https=) |
| EP (1) | EP4247492A1 (https=) |
| JP (1) | JP2023550122A (https=) |
| KR (1) | KR20230112678A (https=) |
| CN (1) | CN116528857A (https=) |
| AU (1) | AU2021381009A1 (https=) |
| CA (1) | CA3196526A1 (https=) |
| CO (1) | CO2023007626A2 (https=) |
| GB (1) | GB202018412D0 (https=) |
| IL (1) | IL303036A (https=) |
| MX (1) | MX2023005928A (https=) |
| WO (1) | WO2022106857A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202345806A (zh) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | 噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑 |
| EP4638458A1 (en) * | 2022-12-23 | 2025-10-29 | Janssen Pharmaceutica NV | Malt1 inhibitors |
| CN121419973A (zh) * | 2023-06-30 | 2026-01-27 | 詹森药业有限公司 | Malt1抑制剂 |
| WO2025059027A1 (en) * | 2023-09-11 | 2025-03-20 | Schrödinger, Inc. | Cyclopenta[e]pyrazolo[1,5-a]pyrimidine derivatives as malt1 inhibitors |
| WO2025223516A1 (zh) * | 2024-04-24 | 2025-10-30 | 首药控股(北京)股份有限公司 | 一种抑制剂杂环化合物 |
| WO2025223551A1 (en) * | 2024-04-26 | 2025-10-30 | Janssen Pharmaceutica Nv | Formulations, crystalline forms and dosage regimens of a malt1 inhibitor |
| WO2025224298A1 (en) * | 2024-04-26 | 2025-10-30 | Janssen Pharmaceutica Nv | Inhibitors of malt1 and methods of their use |
| WO2026003045A1 (en) | 2024-06-26 | 2026-01-02 | Janssen Pharmaceutica Nv | Synthesis of a malt1 inhibitor |
| WO2026003049A1 (en) * | 2024-06-26 | 2026-01-02 | Janssen Pharmaceutica Nv | Malt1 inhibitors |
| WO2026003043A1 (en) * | 2024-06-26 | 2026-01-02 | Janssen Pharmaceutica Nv | Malt1 inhibitors |
| WO2026003039A1 (en) * | 2024-06-26 | 2026-01-02 | Janssen Pharmaceutica Nv | Malt1 inhibitors |
| WO2026003051A1 (en) * | 2024-06-26 | 2026-01-02 | Janssen Pharmaceutica Nv | Crystalline forms |
| WO2026017148A1 (zh) * | 2024-07-19 | 2026-01-22 | 上海拓界生物医药科技有限公司 | 一种malt1抑制剂及其制备方法和用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0012240D0 (en) | 2000-05-19 | 2000-07-12 | Merck Sharp & Dohme | Therapeutic agents |
| DE10132686A1 (de) * | 2001-07-05 | 2003-01-16 | Boehringer Ingelheim Pharma | Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| JP2006522127A (ja) * | 2003-04-01 | 2006-09-28 | スミスクライン ビーチャム コーポレーション | イミダゾトリアジン化合物 |
| ME01526B (me) * | 2009-02-26 | 2014-04-20 | Boehringer Ingelheim Int | Jedinjenja kao b1 antagonisti bradikinina |
| GB0920382D0 (en) | 2009-11-20 | 2010-01-06 | Univ Dundee | Design of molecules |
| KR102104125B1 (ko) * | 2011-04-21 | 2020-05-29 | 재단법인 한국파스퇴르연구소 | 소염 화합물 |
| UY34615A (es) * | 2012-02-10 | 2013-09-30 | Galapagos Nv | Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias. |
| US9493481B2 (en) * | 2012-02-23 | 2016-11-15 | Vanderbilt University | Substituted 5-aminothieno[2,3—C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| JPWO2015098991A1 (ja) * | 2013-12-26 | 2017-03-23 | 東レ株式会社 | Ｎ−アルキルアミド誘導体及びその医薬用途 |
| SG11201607895PA (en) | 2014-05-28 | 2016-12-29 | Novartis Ag | Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors |
| SG11201709837RA (en) * | 2015-05-29 | 2017-12-28 | Teijin Pharma Ltd | PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
| US9708333B2 (en) * | 2015-08-12 | 2017-07-18 | Incyte Corporation | Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors |
| AU2016352813B2 (en) | 2015-11-13 | 2019-09-19 | Novartis Ag | Novel pyrazolo pyrimidine derivatives |
| JP6902040B2 (ja) * | 2016-01-28 | 2021-07-14 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 免疫チェックポイント阻害剤の効力を増強する方法 |
| WO2018078042A1 (en) * | 2016-10-28 | 2018-05-03 | H. Lundbeck A/S | Combination treatments comprising administration of imidazopyrazinones |
| TWI795381B (zh) * | 2016-12-21 | 2023-03-11 | 比利時商健生藥品公司 | 作為ｍａｌｔ１抑制劑之吡唑衍生物 |
| JP2018135274A (ja) * | 2017-02-20 | 2018-08-30 | Ａｇｃ株式会社 | 多環芳香族炭化水素を光触媒とするフルオロメチル基含有化合物の製造方法 |
| JP6891047B2 (ja) * | 2017-05-31 | 2021-06-18 | 国立大学法人 名古屋工業大学 | 光学活性トリフルオロメチル基含有アミノ酸誘導体の製造方法 |
| WO2018226150A1 (en) * | 2017-06-05 | 2018-12-13 | Medivir Aktiebolag | Pyrazolopyrimidine as malt-1 inhibitors |
| TWI848400B (zh) | 2018-11-28 | 2024-07-11 | 日商武田藥品工業股份有限公司 | 雜環化合物及醫藥 |
| JP7818011B2 (ja) * | 2020-10-16 | 2026-02-19 | レラファイド バイオサイエンシーズ， インコーポレイテッド | Ｍａｌｔ１モジュレーターおよびその使用 |
| WO2022081995A1 (en) * | 2020-10-16 | 2022-04-21 | Rheos Medicines, Inc. | Malt1 modulators and uses thereof |
-
2020
- 2020-11-23 GB GBGB2018412.3A patent/GB202018412D0/en not_active Ceased
-
2021
- 2021-11-23 JP JP2023530634A patent/JP2023550122A/ja active Pending
- 2021-11-23 IL IL303036A patent/IL303036A/en unknown
- 2021-11-23 CA CA3196526A patent/CA3196526A1/en active Pending
- 2021-11-23 CN CN202180078754.7A patent/CN116528857A/zh active Pending
- 2021-11-23 US US18/253,572 patent/US20250051327A1/en active Pending
- 2021-11-23 MX MX2023005928A patent/MX2023005928A/es unknown
- 2021-11-23 WO PCT/GB2021/053031 patent/WO2022106857A1/en not_active Ceased
- 2021-11-23 AU AU2021381009A patent/AU2021381009A1/en active Pending
- 2021-11-23 KR KR1020237021035A patent/KR20230112678A/ko active Pending
- 2021-11-23 EP EP21836594.8A patent/EP4247492A1/en active Pending
-
2023
- 2023-06-09 CO CONC2023/0007626A patent/CO2023007626A2/es unknown
-
2025
- 2025-12-18 US US19/424,423 patent/US20260109698A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023550122A5 (https=) | ||
| JP2023505258A5 (https=) | ||
| RU2014110623A (ru) | Пирролопиразиновые ингибиторы киназы | |
| JP2024512154A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| RU2405780C2 (ru) | Химические соединения | |
| RU2015122757A (ru) | Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли | |
| JP2018507877A5 (https=) | ||
| JP2019038820A5 (https=) | ||
| JP2004520324A5 (https=) | ||
| JP2022552655A5 (https=) | ||
| JP2013056930A5 (https=) | ||
| RU2014114973A (ru) | Пиразол-4-ил-гетероциклил-карбоксамидные соединения и способы применения | |
| JP2022505525A5 (https=) | ||
| JP2019510798A5 (https=) | ||
| JP2021535207A5 (https=) | ||
| RU2004126671A (ru) | Гетероарилсоединения, полезные в качестве ингибиторов gsk-3 | |
| JP2017525757A5 (https=) | ||
| RU2016101548A (ru) | Соединения амидов гетероарилпиридона и азапиридона | |
| RU2015143675A (ru) | Ship1 модуляторы и относящиеся к ним способы | |
| JP2016516028A5 (https=) | ||
| JP2014506599A5 (https=) | ||
| JP2009544600A5 (https=) | ||
| JP2015511629A5 (https=) | ||
| JP2017519754A5 (https=) |